Non-invasive prenatal testing (NIPT) uses cell-free DNA (cfDNA) derived from the pregnancy to evaluate possible chromosomal conditions in a pregnancy. NIPT is a prenatal screening test that can be performed as early as 10 weeks of pregnancy using a single blood draw. Prenatal diagnostic tests such as amniocentesis and Chorionic Villus Sampling (CVS) diagnose the presence of chromosomal conditions. They are typically performed later in pregnancy and are associated with a small risk of pregnancy loss.
The Harmony® prenatal test is a type of non-invasive prenatal test (NIPT), which can also be called NIPS (non-invasive prenatal screening). It looks at fragments of your baby’s DNA in your blood to provide accurate information about the likelihood for the most common chromosomal conditions as early as 10 weeks. It can also identify the sex of your baby.
The Harmony test screens for the most common chromosomal conditions including: